A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
Coplan
J D
JD
New York State Psychiatric Institute, New York, USA.
Pine
D S
DS
Papp
L A
LA
Gorman
J M
JM
D000818:Animals; D001007:Anxiety / Q000503:physiopathology*; D003000:Clonidine / Q000494:pharmacology*; D003346:Corticotropin-Releasing Hormone / Q000502:physiology*; D003866:Depressive Disorder / Q000503:physiopathology; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000502:physiology*; D019964:Mood Disorders / Q000503:physiopathology*; D016584:Panic Disorder / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000502:physiology*; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects / Q000502:physiology*; D013313:Stress Disorders, Post-Traumatic / Q000503:physiopathology
D018341:Receptors, Adrenergic, alpha-2; D013006:Growth Hormone; D003346:Corticotropin-Releasing Hormone; D003000:Clonidine